FDA Drug Application (018932) for REVIA by TEVA WOMENS

Back to FDA Applications sponsored by TEVA WOMENS

Application Number018932
Product Number001
FormTABLET;ORAL
Dosage50MG
Product Market Status Prescription
Therapeutic Equivalence Evaluation Code AB Products meeting necessary bioequivalence requirements
Reference Drug
Drug NameREVIA
Active IngredientNALTREXONE HYDROCHLORIDE

Active IngredientCount
List of drugs with Active Ingredient NALTREXONE HYDROCHLORIDE5


Back to FDA Applications sponsored by TEVA WOMENS